TREXALL Side Effects

6443984-2 | Incorrect Dose Administered, Mental Disorder, Skin Laceration, Suicide Attempt
on Nov 17, 2009 Female patient from UNITED STATES , 33 years of age, weighting 140.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Trexall (View Usage). Patient experienced the following unwanted or unexpected effects: incorrect dose administered, mental disorder, skin laceration, suicide attempt. Trexall dosage: 15 Mg 1 X Day Po. Patient was hospitalized.

5779762-7 | B-cell Lymphoma Stage Iv, Epstein-barr Virus Test Positive
Patient was taking Trexall (View Usage). Patient had the following side effects: b-cell lymphoma stage iv, epstein-barr virus test positive on Jun 10, 2008 from CANADA Additional patient health information: Male patient , 56 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and. Trexall dosage: 7.5 Mg, 1/week,. During the same period patient was treated with ENBREL (50 Mg, 1/week, Subcutaneous) (View Enbrel Review and Enbrel Label ).

5779757-3 | Chronic Myeloid Leukaemia
Adverse event was reported on Jun 10, 2008 by a Female patient taking Trexall (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: BELGIUM , 45 years of age, After Trexall was administered, patient had the following side effects: chronic myeloid leukaemia. During the same period patient was treated with ENBREL (50 Mg, 1/week, Subcutaneous) (View Enbrel Review and Enbrel Label ).

5778740-1 | Disorientation, Flushing, Hepatic Enzyme Increased, Hypertension
on Jun 10, 2008 Male patient from UNITED STATES , 42 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Trexall (View Usage). Patient experienced the following unwanted or unexpected effects: disorientation, flushing, hepatic enzyme increased, hypertension. Trexall dosage: . During the same period patient was treated with ENBREL (50 Mg, 1/week, Subcutaneous) (View Enbrel Review and Enbrel Label ).


5776670-2 | Acute Myocardial Infarction, Joint Injury, Necrotising Fasciitis Streptococcal, Purulence, Renal Failure, Septic Shock, Skin Laceration, Wound
on Jun 10, 2008 Male patient from CANADA , 53 years of age, weighting 183.2 lb, was diagnosed with psoriasis and was treated with Trexall (View Usage). Patient had the following side effects: acute myocardial infarction, joint injury, necrotising fasciitis streptococcal, purulence, renal failure, septic shock, skin laceration, wound (What is wound?). Trexall dosage: 15 Mg, 1/week, Oral. During the same period patient was treated with ENBREL (50 Mg, 2/week, Subcutaneous) (View Enbrel Review and Enbrel Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized.

5193826-0 | Blood Creatinine Increased, Blood Urea Increased, Escherichia Infection, Hydronephrosis, Pancytopenia, Pathogen Resistance, Pyelonephritis, Staphylococcal Sepsis, Stent Occlusion
Patient was taking Trexall (View Usage). After Trexall was administered, patient had the following side effects: blood creatinine increased, blood urea increased, escherichia infection, hydronephrosis, pancytopenia, pathogen resistance, pyelonephritis, staphylococcal sepsis, stent occlusion on Dec 11, 2006 from UNITED STATES Additional patient health information: Female patient , 66 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Trexall dosage: See Image. During the same period patient was treated with KINERET (100 Mg, Qd, Subcutaneous) (View Kineret Review and Kineret Label ), LEVOTHYROINE (LEOVTHYROXINE) (View Levothyroine (leovthyroxine) Review and Levothyroine (leovthyroxine) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

5193695-9 | Escherichia Urinary Tract Infection, Hydronephrosis, Pancytopenia, Pyelonephritis, Staphylococcal Sepsis, Stent Occlusion, Urosepsis
Adverse event was reported on Dec 21, 2006 by a Female patient taking Trexall (View Usage) (Dosage: 25 + 15 Mg, 1/week, Oral- See Image) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 66 years of age, Patient experienced the following unwanted or unexpected effects: escherichia urinary tract infection, hydronephrosis, pancytopenia, pyelonephritis, staphylococcal sepsis, stent occlusion, urosepsis. During the same period patient was treated with KINERET (100 Mg, Qd, Subcutaneous) (View Kineret Review and Kineret Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), MORPHINE (View Morphine Review and Morphine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.